Physician profile
Christopher Alan Sendi
NPI 1295714475
$3,614.18
in general payments reported to CMS, 2019-2025
18 companies · $847 in 2025
The $847 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $85.14 · 2021: $35.40 · 2022: $1,557 · 2023: $350 · 2024: $739 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908 · Education: $28.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.08 |
| Education | $28.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,454.85 | 2022 | |
| Abbvie INC. | $456.41 | 2021-2025 | Vraylar |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $402.24 | 2023-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $279.23 | 2023-2025 | Trintellix |
| Vanda Pharmaceuticals INC. | $263.01 | 2024-2025 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $199.50 | 2023-2025 | Auvelity |
| Braeburn INC. | $135.29 | 2023-2025 | Brixadi |
| Lilly USA, LLC | $107.22 | 2024-2025 | Zepbound, Jardiance |
| Allergan, INC. | $69.94 | 2020 | |
| Hikma Pharmaceuticals USA | $61.37 | 2022 | |
| Indivior INC. | $55.31 | 2020-2025 | Sublocade |
| Tms Neurohealth Centers INC. | $29.94 | 2025 | Tms Neurohealth Centers INC. |
| Pfizer INC. | $22.78 | 2025 | |
| Orexo US, INC. | $18.30 | 2021 | |
| Novo Nordisk INC | $17.07 | 2023 | Wegovy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $15.21 | 2022 | |
| Corium, LLC | $13.45 | 2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sendi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.